99 related articles for article (PubMed ID: 12698235)
1. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
Jonsson KO; Andersson A; Jacobsson SO; Vandevoorde S; Lambert DM; Fowler CJ
Arch Toxicol; 2003 Apr; 77(4):201-7. PubMed ID: 12698235
[TBL] [Abstract][Full Text] [Related]
2. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.
Jacobsson SO; Wallin T; Fowler CJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):951-9. PubMed ID: 11714882
[TBL] [Abstract][Full Text] [Related]
4. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
Kelley BG; Thayer SA
Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.
Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D
Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856
[TBL] [Abstract][Full Text] [Related]
6. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
7. The anandamide transport inhibitor AM404 activates vanilloid receptors.
Zygmunt PM; Chuang H; Movahed P; Julius D; Högestätt ED
Eur J Pharmacol; 2000 May; 396(1):39-42. PubMed ID: 10822052
[TBL] [Abstract][Full Text] [Related]
8. The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain.
Murillo-Rodríguez E; Millán-Aldaco D; Di Marzo V; Drucker-Colín R
Neuroscience; 2008 Nov; 157(1):1-11. PubMed ID: 18822353
[TBL] [Abstract][Full Text] [Related]
9. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
[TBL] [Abstract][Full Text] [Related]
10. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
Vandevoorde S; Lambert DM; Smart D; Jonsson KO; Fowler CJ
Bioorg Med Chem; 2003 Mar; 11(6):817-25. PubMed ID: 12614867
[TBL] [Abstract][Full Text] [Related]
11. Anandamide transport inhibition by the vanilloid agonist olvanil.
Beltramo M; Piomelli D
Eur J Pharmacol; 1999 Jan; 364(1):75-8. PubMed ID: 9920187
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
Giuffrida A; Beltramo M; Piomelli D
J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
[TBL] [Abstract][Full Text] [Related]
13. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain.
Costa B; Siniscalco D; Trovato AE; Comelli F; Sotgiu ML; Colleoni M; Maione S; Rossi F; Giagnoni G
Br J Pharmacol; 2006 Aug; 148(7):1022-32. PubMed ID: 16770320
[TBL] [Abstract][Full Text] [Related]
14. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
Rodella LF; Borsani E; Rezzani R; Ricci F; Buffoli B; Bianchi R
Eur J Pharmacol; 2005 Jan; 508(1-3):139-46. PubMed ID: 15680264
[TBL] [Abstract][Full Text] [Related]
15. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
16. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.
Smart D; Jonsson KO; Vandevoorde S; Lambert DM; Fowler CJ
Br J Pharmacol; 2002 Jun; 136(3):452-8. PubMed ID: 12023948
[TBL] [Abstract][Full Text] [Related]
17. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.
Beltramo M; de Fonseca FR; Navarro M; Calignano A; Gorriti MA; Grammatikopoulos G; Sadile AG; Giuffrida A; Piomelli D
J Neurosci; 2000 May; 20(9):3401-7. PubMed ID: 10777802
[TBL] [Abstract][Full Text] [Related]
18. Functional role of high-affinity anandamide transport, as revealed by selective inhibition.
Beltramo M; Stella N; Calignano A; Lin SY; Makriyannis A; Piomelli D
Science; 1997 Aug; 277(5329):1094-7. PubMed ID: 9262477
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
